New study tests drug combo to predict best weight loss treatment
NCT ID NCT06619015
First seen Apr 25, 2026 · Last updated Jun 12, 2026 · Updated 13 times
Summary
This study looked at whether adding pramlintide to semaglutide changes appetite and eating habits in obese adults with prediabetes. Researchers planned to give 40 participants weekly semaglutide for 24 weeks, then add either pramlintide or placebo for two more weeks. The goal was to find ways to predict who will respond best to obesity medications, leading to more personalized treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University hospital of Southern Denmark
Esbjerg, 6700, Denmark
Conditions
Explore the condition pages connected to this study.